STERIS plc Interest Expense Nonoperating
STERIS plc (STE) reported Interest Expense Nonoperating of $15.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-08-07
- STERIS plc interest expense nonoperating for the quarter ending 2026-06-30 was $15.80M, a 0.63% decline year-over-year.
- STERIS plc interest expense nonoperating for the quarter ending 2026-03-31 was $15.10M, a 12.21% decline year-over-year.
- STERIS plc interest expense nonoperating for the quarter ending 2025-12-31 was $14.90M, a 21.99% decline year-over-year.
- STERIS plc interest expense nonoperating for the quarter ending 2025-09-30 was $14.90M, a 24.37% decline year-over-year.
- STERIS plc interest expense nonoperating for fiscal 2026 was $60.70M, a 29.66% decline from fiscal 2025.
- STERIS plc interest expense nonoperating for fiscal 2025 was $86.30M, a 40.24% decline from fiscal 2024.
- STERIS plc interest expense nonoperating for fiscal 2024 was $144.40M, a 33.76% increase from fiscal 2023.
- STERIS plc interest expense nonoperating for fiscal 2023 was $107.96M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 3 month as first filed | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 6 month as first filed | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 9 month as first filed | Interest Expense Nonoperating 12 month | Interest Expense Nonoperating 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.80M 10-Q · filed 2026-08-07 | $30.90M derived: sum of 2 quarters · filed 2026-08-07 | $45.80M derived: sum of 3 quarters · filed 2026-08-07 | $60.70M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $15.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $30.00M derived: sum of 2 quarters · filed 2026-05-29 | $44.90M derived: sum of 3 quarters · filed 2026-05-29 | $60.70M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $14.90M 10-Q · filed 2026-02-06 | $29.80M derived: sum of 2 quarters · filed 2026-02-06 | $45.60M 10-Q · filed 2026-02-06 | $62.90M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $14.90M 10-Q · filed 2025-11-06 | $30.70M 10-Q · filed 2025-11-06 | $48.00M derived: sum of 3 quarters · filed 2026-08-07 | $67.10M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $15.90M 10-Q · filed 2026-08-07 | $33.10M derived: sum of 2 quarters · filed 2026-08-07 | $52.20M derived: sum of 3 quarters · filed 2026-08-07 | $71.90M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $17.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $36.30M derived: sum of 2 quarters · filed 2026-05-29 | $56.00M derived: sum of 3 quarters · filed 2026-05-29 | $86.30M 10-K · filed 2026-05-29 | $86.26M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $19.10M 10-Q · filed 2026-02-06 | $19.09M 10-Q · filed 2025-02-07 | $38.80M derived: sum of 2 quarters · filed 2026-02-06 | $69.10M 10-Q · filed 2026-02-06 | $69.15M 10-Q · filed 2025-02-07 | $105.36M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-09-30 | $19.70M 10-Q · filed 2025-11-06 | $19.67M 10-Q · filed 2024-11-07 | $50.10M 10-Q · filed 2025-11-06 | $50.05M 10-Q · filed 2024-11-07 | $86.26M derived: sum of 3 quarters · filed 2026-05-29 | $125.20M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-06-30 | $30.40M 10-Q · filed 2025-08-07 | $66.56M derived: sum of 2 quarters · filed 2026-05-29 | $105.50M derived: sum of 3 quarters · filed 2026-05-29 | $142.44M derived: sum of 4 quarters · filed 2026-05-29 | ||||
| 2024-03-31 | $36.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $75.11M derived: sum of 2 quarters · filed 2026-05-29 | $112.04M derived: sum of 3 quarters · filed 2026-05-29 | $144.40M 10-K · filed 2026-05-29 | $144.35M 10-K · filed 2025-05-29 | |||
| 2023-12-31 | $38.95M 10-Q · filed 2025-02-07 | $75.89M derived: sum of 2 quarters · filed 2025-02-07 | $108.24M 10-Q · filed 2025-02-07 | |||||
| 2023-09-30 | $36.94M 10-Q · filed 2024-11-07 | $69.30M 10-Q · filed 2024-11-07 | ||||||
| 2023-03-31 | $107.96M 10-K · filed 2025-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |